Physician profile
Rosa Eyton
NPI 1760093751
$6,607.96
in general payments reported to CMS, 2019-2025
9 companies · $3,493 in 2025
The $3,493 reported for 2025 was more than what 98% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,200 · 2022: $94.35 · 2023: $1,798 · 2024: $22.53 · 2025: $3,493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,946 · Food and Beverage: $1,367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,946.40 |
| Food and Beverage | $1,367.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sioux Surgical INC | $3,240.27 | 2021-2025 | |
| Smith+Nephew, INC. | $2,224.75 | 2022-2025 | Pico, Grafix, Versajet |
| Arthrex, INC. | $982.22 | 2023-2025 | |
| Stryker Corporation | $47.71 | 2025 | Alphavent |
| Zimmer Biomet Holdings, INC. | $31.67 | 2022 | |
| Organogenesis INC. | $24.27 | 2025 | Puraply Wound Matrix |
| Tactile Systems Technology INC | $22.53 | 2024 | Entre Plus, Flexitouch Plus |
| Solventum Corporation | $21.09 | 2025 | V.A.C. Veraflo, Activ.A.C. |
| Vericel Corporation | $13.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rosa Eyton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.